Clinical Trial Update: Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934 [Phase 2]

View source ↗

Summary

Phase 2 trial update comparing maintenance treatment of anemia in chronic kidney disease patients on Epoetin alfa/beta versus BAY85-3934 in hemodialysis subject…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• BAY85-3934
• Epoetin alfa / beta (epoetin alfa)

Snippet

Sponsor: Bayer | Conditions: Anemia, Renal Insufficiency, Chronic | Phase 2 | Status: COMPLETED